This finding positioned GLP-1 receptor agonists not merely as metabolic drugs but as cardiovascular therapeutics, a distinction that carries particular relevance for menopausal women, whose cardiovascular risk accelerates significantly during and after the transition
In one 68-week trial with over 1,900 obese participants, those who took Wegovy lost an average of 15% of their initial body weight compared to only 2.4% weight loss in the placebo group
After starting Mounjaro, document any side effects or reactions
What to Watch For: Red Flags and Regulatory Trends The FDA may increase scrutiny of specific compounders who demonstrate quality failures, misbranding, or false advertisingbut this targets bad actors, not compounding itself
Fragrance scents and notes The interest in vanilla scents reflects a consumer preference for familiar and comforting fragrances
What were seeing with rapid weight loss isnt just volume depletion but a complete restructuring of skin architecture, he says
